PCM
CLBT icon

Portolan Capital Management’s Cellebrite CLBT Stock Holding History

Portolan Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2M Sell
1,932,514
-248,410
-11% -$3.28M 1.06% 28
2026
Q1 		$30.1M Buy
2,180,924
+893,637
+69% +$13.5M 1.6% 17
2025
Q4 		$23.2M Sell
1,287,287
-1,132,375
-47% -$20.3M 1.24% 22
2025
Q3 		$44.8M Buy
2,419,662
+1,407,818
+139% +$22.1M 2.43% 10
2025
Q2 		$16.2M Buy
1,011,844
+22,852
+2% +$407K 1.02% 33
2025
Q1 		$19.2M Buy
988,992
+74,136
+8% +$1.56M 1.46% 25
2024
Q4 		$20.2M Sell
914,856
-309,164
-25% -$5.95M 1.36% 21
2024
Q3 		$20.6M Buy
1,224,020
+203,068
+20% +$3.01M 1.49% 15
2024
Q2 		$12.2M Sell
1,020,952
-122,720
-11% -$1.37M 1% 32
2024
Q1 		$12.7M Buy
+1,143,672
New +$11.7M 0.97% 38

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Portolan Capital Management's CLBT Position: Q2 2026 in Review

Portolan Capital Management reduced its Cellebrite (CLBT) stake by 11% in Q2 2026, selling an estimated $3.28M and leaving 1,932,514 shares worth $28.2M. The position accounts for 1.06% of the portfolio, ranked #28.

Portolan Capital Management first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $44.8M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Portolan Capital Management held 1,932,514 shares of Cellebrite worth $28.2M as of Q2 2026.
  • Portolan Capital Management sold 248,410 Cellebrite shares in Q2 2026, an estimated $3.28M.
  • Cellebrite made up 1.06% of Portolan Capital Management's portfolio in Q2 2026, its #28 holding.
  • Portolan Capital Management first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
  • Portolan Capital Management's Cellebrite position peaked at $44.8M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Portolan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.